Literature DB >> 8132974

A seroepidemiological study of human Toxocara infection in the Slovak Republic.

K Havasiová1, P Dubinský, A Stefancíková.   

Abstract

Sera of 908 blood donors, average age 35 years, living in towns and villages of the Slovak Republic were tested for Toxocara canis antibodies using an ELISA-IgG test. The seroprevalence in the healthy population was estimated at 13.65%. Antibodies were predominantly demonstrated in the sera from persons living in rural communities (17.09%) compared to the sera investigated from urban communities (11.82%). Women had a significantly higher seropositivity than men. The serological response in 2703 sera from patients suspected of toxocarosis was compared with their clinical manifestation, sex and age. Toxocara antibodies were found in 27.41% of suspected patients. Although the seroprevalence in adults was significantly higher among women than men, in children, boys had a higher seroprevalence than girls. The main clinical manifestations were leucocytosis and eosinophilia (46%), ocular disorders (36%), lung, liver and neurological disorders (26%). The most severe forms of this disease were observed in 2 to 5-year-old children with geophagy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8132974     DOI: 10.1017/s0022149x00013298

Source DB:  PubMed          Journal:  J Helminthol        ISSN: 0022-149X            Impact factor:   2.170


  11 in total

1.  Toxocara canis larvae viability after disinfectant-exposition.

Authors:  P Morrondo; C Díez-Morrondo; J Pedreira; N Díez-Baños; R Sánchez-Andrade; A Paz-Silva; P Díez-Baños
Journal:  Parasitol Res       Date:  2006-04-26       Impact factor: 2.289

2.  Toxocara infection in the United States: the relevance of poverty, geography and demography as risk factors, and implications for estimating county prevalence.

Authors:  Peter Congdon; Patsy Lloyd
Journal:  Int J Public Health       Date:  2010-04-27       Impact factor: 3.380

3.  Seroprevalence of human toxocariasis in Denmark.

Authors:  Christen R Stensvold; Jakob Skov; Lone N Møller; Per M Jensen; Christian M O Kapel; Eskild Petersen; Henrik V Nielsen
Journal:  Clin Vaccine Immunol       Date:  2009-07-29

4.  Anti-Toxocara spp. antibodies in an adult healthy population: serosurvey and risk factors in Southeast Brazil.

Authors:  Elaine Cristina Negri; Vamilton Alvares Santarém; Guita Rubinsky-Elefant; Rogério Giuffrida
Journal:  Asian Pac J Trop Biomed       Date:  2013-03

5.  Assessment of the diagnostic value of specific anti-Toxocara IgA in Slovakian patients suspected to have toxocarosis.

Authors:  Vojtech Boldiš; František Ondriska; Simona Lipková
Journal:  Folia Microbiol (Praha)       Date:  2017-12-06       Impact factor: 2.099

6.  Effect of various doses of infective Toxocara canis and Toxocara cati eggs on the humoral response and distribution of larvae in mice.

Authors:  K Havasiová-Reiterová; O Tomasovicová; P Dubinský
Journal:  Parasitol Res       Date:  1995       Impact factor: 2.289

7.  Frequency of Toxocariasis among Patients Clinically Suspected to Have Visceral Toxocariasis: A Retrospective Descriptive Study in Sri Lanka.

Authors:  Devika Iddawela; Kiruthiha Ehambaram; Dhilma Atapattu; Kalyani Pethiyagoda; Lakmalee Bandara
Journal:  J Parasitol Res       Date:  2017-12-06

8.  Serological Evidence of Exposure to Globally Relevant Zoonotic Parasites in the Estonian Population.

Authors:  Brian Lassen; Marilin Janson; Arvo Viltrop; Kädi Neare; Pirje Hütt; Irina Golovljova; Lea Tummeleht; Pikka Jokelainen
Journal:  PLoS One       Date:  2016-10-10       Impact factor: 3.240

9.  Small rodents as paratenic or intermediate hosts of carnivore parasites in Berlin, Germany.

Authors:  Jürgen Krücken; Julia Blümke; Denny Maaz; Janina Demeler; Sabrina Ramünke; Daniela Antolová; Roland Schaper; Georg von Samson-Himmelstjerna
Journal:  PLoS One       Date:  2017-03-09       Impact factor: 3.240

10.  Low Toxocara Seroprevalence in People in Rural Durango, Mexico.

Authors:  Cosme Alvarado-Esquivel; Ángel Osvaldo Alvarado-Félix; Gustavo Alexis Alvarado-Félix
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2019-08-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.